The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment
Open accessAbstract
Taking inspiration from nature, the biomimetic concept has been integrated into drug delivery systems in cancer therapy. Disguised with cell membranes, the nanoparticles can acquire various functions of natural cells. The cell membrane-coating technology has pushed the limits of common nano-systems (fast elimination in circulation) to more effectively navigate within the body. Moreover, because of the various functional molecules on the surface, cell membrane-based nanoparticles (CMBNPs) are capable of interacting with the complex biological microenvironment of the tumor. Various sources of cell membranes have been explored to camouflage CMBNPs and different tumor-targeting strategies have been developed to enhance the anti-tumor drug delivery therapy. In this review article we highlight the most recent advances in CMBNP-based cancer targeting systems and address the challenges and opportunities in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Decoding the Patterns of Self and Nonself by the Innate Immune System
Medzhitov, R., & Janeway, C. A. (2002) · Science · doi:10.1126/science.1068883 · Cited by 2,154
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Role of CD47 as a Marker of Self on Red Blood Cells
Oldenborg, P.-A., Zheleznyak, A., Fang, Y.-F., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 1,970
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Contribution of platelets to tumour metastasis
Gay, L. J., & Felding-Habermann, B. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3004 · Cited by 1,645
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
The cellular and molecular origin of tumor-associated macrophages
Franklin, R. A., Liao, W., Sarkar, A., Kim, M. V., Bivona, M. R., Liu, K., Pamer, E. G., & Li, M. O. (2014) · Science · doi:10.1126/science.1252510 · Cited by 1,393
Ha, D., Yang, N., & Nadithe, V. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.02.001 · Cited by 1,346
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review
Azmi, A. S., Bao, B., & Sarkar, F. H. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9441-9 · Cited by 1,167
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.006 · Cited by 956
Cancer metastases: challenges and opportunities
Guan, X. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.07.005 · Cited by 952
Chen, Z., Zhao, P., Luo, Z., Zheng, M., Tian, H., Gong, P., Gao, G., Pan, H., Liu, L., Ma, A., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b04695 · Cited by 895
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
Yu, M. K., Park, J., & Jon, S. (2012) · Theranostics · doi:10.7150/thno.3463 · Cited by 883
Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer
Cao, H., Dan, Z., He, X., Zhang, Z., Yu, H., Yin, Q., & Li, Y. (2016) · ACS Nano · doi:10.1021/acsnano.6b03148 · Cited by 694
Anticancer Platelet‐Mimicking Nanovehicles
Hu, Q., Sun, W., Qian, C., Wang, C., Bomba, H. N., & Gu, Z. (2015) · Advanced Materials · doi:10.1002/adma.201503323 · Cited by 630
Cell membrane-camouflaged nanoparticles for drug delivery
Luk, B. T., & Zhang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.019 · Cited by 610
The biogenesis of platelets from megakaryocyte proplatelets
Patel, S. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26891 · Cited by 603
Cancer related inflammation: the macrophage connection
Sica, A., Allavena, P., & Mantovani, A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.028 · Cited by 601
Platelets in inflammation and thrombosis
Wagner, D. D., & Burger, P. C. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000095974.95122.ec · Cited by 570
Annual report on status of cancer in China, 2010
Wanqing, Chen, Rongshou, Zheng, Z., Siwei, Zhang, Ping, P., Zhao, Hongmei, Zeng, et al. (2014) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 565
PEGylated antibodies and antibody fragments for improved therapy: a review
Chapman, A. P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00026-1 · Cited by 556
Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis
Kang, T., Zhu, Q., Wei, D., Feng, J., Yao, J., Jiang, T., Song, Q., Wei, X., Chen, H., Gao, X., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06477 · Cited by 551
Cancer Cell Membrane‐Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging
Rao, L., Bu, L., Cai, B., Xu, J., Li, A., Zhang, W., Sun, Z., Guo, S., Liu, W., Wang, T., et al. (2016) · Advanced Materials · doi:10.1002/adma.201506086 · Cited by 530
Yoo, J.-W., Chambers, E., & Mitragotri, S. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791920496 · Cited by 521
Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles
Gao, W., Fang, R. H., Thamphiwatana, S., Luk, B. T., Li, J., Angsantikul, P., Zhang, Q., Hu, C.-M. J., & Zhang, L. (2015) · Nano Letters · doi:10.1021/nl504798g · Cited by 509
Tumour-released exosomes and their implications in cancer immunity
Iero, M., Valenti, R., Huber, V, Filipazzi, P., Parmiani, G., Fais, S., & Rivoltini, L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402237 · Cited by 485
Cell membrane-derived nanomaterials for biomedical applications
Fang, R. H., Jiang, Y., Fang, J. C., & Zhang, L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.041 · Cited by 468
Leukocyte extravasation: chemokine transport and presentation by the endothelium
Middleton, J., Patterson, A. M., Gardner, L., Schmutz, C., & Ashton, B. A. (2002) · Blood · doi:10.1182/blood.v100.12.3853 · Cited by 456
Annual report on status of cancer in China, 2010.
Chen, W., Zheng, R., Zhang, S., Zhao, P., Zeng, H., Zou, X., & He, J. (2014) · PubMed · doi:10.3978/j.issn.1000-9604.2014.01.08 · Cited by 378
Self-citationXuan, M., Shao, J., Dai, L., Li, J., & He, Q. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b00853 · Cited by 376
Annual report on status of cancer in China, 2011.
Chen, W., Zheng, R., Zeng, H., Zhang, S., & He, J. (2015) · PubMed · doi:10.3978/j.issn.1000-9604.2015.01.06 · Cited by 373
Self-citationWang, Q., Ren, Y., Mu, J., Egilmez, N. K., Zhuang, X., Deng, Z., Zhang, L., Yan, J., Miller, D., & Zhang, H.-G. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3095 · Cited by 366
Nash, G., Turner, L., Scully, M., & Kakkar, A. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00789-1 · Cited by 366
Stem Cell Membrane‐Coated Nanogels for Highly Efficient In Vivo Tumor Targeted Drug Delivery
Gao, C., Lin, Z., Jurado‐Sánchez, B., Lin, X., Wu, Z., & He, Q. (2016) · Small · doi:10.1002/smll.201600624 · Cited by 359
Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy
Xuan, M., Shao, J., Dai, L., He, Q., & Li, J. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500129 · Cited by 352
Chen, S., Zhu, J.-H., Wang, F., Huang, S.-Y., Xue, W.-Q., Cui, Z., He, J., & Jia, W.-H. (2015) · Chinese Journal of Cancer · doi:10.1186/s40880-015-0001-2 · Cited by 352
Sun, H., Su, J., Meng, Q., Yin, Q., Chen, L., Gu, W., Zhang, Z., Yu, H., Zhang, P., Wang, S., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201604300 · Cited by 352
Erythrocyte programmed cell death
Föller, M., Huber, S. M., & Lang, F. (2008) · IUBMB Life · doi:10.1002/iub.106 · Cited by 314
Hu, C.-M. J., Fang, R. H., Luk, B. T., Chen, K. N. H., Carpenter, C., Gao, W., Zhang, K., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr00015j · Cited by 308
Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles
Fang, R. H., Hu, C.-M. J., Chen, K. N. H., Luk, B. T., Carpenter, C. W., Gao, W., Li, S., Zhang, D.-E., Lu, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr03064d · Cited by 302
Endo- and Exocytosis of Zwitterionic Quantum Dot Nanoparticles by Live HeLa Cells
Jiang, X., Röcker, C., Hafner, M., Brandholt, S., Dörlich, R. M., & Nienhaus, G. U. (2010) · ACS Nano · doi:10.1021/nn101277w · Cited by 299
Pierigè, F., Serafini, S., Rossi, L., & Magnani, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.029 · Cited by 295
Therapeutic Cancer Vaccines: Current Status and Moving Forward
Schlom, J. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs033 · Cited by 282
Glinsky, V. V., Glinsky, G. V., Glinskii, O. V., Huxley, V. H., Turk, J. R., Mossine, V. V., Deutscher, S. L., Pienta, K. J., & Quinn, T. P. (2004) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2003.12.009 · Cited by 266
Luk, B. T., Fang, R. H., Hu, C.-M. J., Copp, J. A., Thamphiwatana, S., Dehaini, D., Gao, W., Zhang, K., Li, S., & Zhang, L. (2016) · Theranostics · doi:10.7150/thno.14471 · Cited by 247
Harker, L. A., Roskos, L. K., Marzec, U. M., Carter, R. A., Cherry, J. K., Sundell, B., Cheung, E. N., Terry, D., & Sheridan, W. (2000) · Blood · doi:10.1182/blood.v95.8.2514 · Cited by 228
Neutrophils: important contributors to tumor progression and metastasis
Swierczak, A., Mouchemore, K. A., Hamilton, J. A., & Anderson, R. L. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9594-9 · Cited by 220
Khaldoyanidi, S. K., Glinsky, V. V., Sikora, L., Glinskii, A. B., Mossine, V. V., Quinn, T. P., Glinsky, G. V., & Sriramarao, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209590200 · Cited by 211
Antitumor Platelet‐Mimicking Magnetic Nanoparticles
Rao, L., Bu, L., Meng, Q., Cai, B., Deng, W., Li, A., Li, K., Guo, S., Zhang, W., Liu, W., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201604774 · Cited by 210
Glinsky, V. V., Glinsky, G. V., Glinskii, O. V., Huxley, V. H., Turk, J. R., Mossine, V. V., Deutscher, S. L., Pienta, K. J., & Quinn, T. P. (2003) · PubMed · Cited by 186
Su, J., Sun, H., Meng, Q., Yin, Q., Zhang, P., Zhang, Z., Yu, H., & Li, Y. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201603381 · Cited by 177
Monocyte cell membrane-derived nanoghosts for targeted cancer therapy
Krishnamurthy, S., Gnanasammandhan, M. K., Xie, C., Huang, K., Cui, M. Y., & Chan, J. M. (2016) · Nanoscale · doi:10.1039/c5nr07588b · Cited by 164
The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?
Lubich, C., Allacher, P., de la Rosa, M., Bauer, A., Prenninger, T., Horling, F. M., Siekmann, J., Oldenburg, J., Scheiflinger, F., & Reipert, B. M. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1961-x · Cited by 164
Exploiting macrophages as targeted carrier to guide nanoparticles into glioma
Pang, L., Qin, J., Han, L., Zhao, W., Liang, J., Xie, Z., Yang, P., & Wang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9464 · Cited by 159
Self-citationCoating nanoparticles with cell membranes for targeted drug delivery
Gao, W., & Zhang, L. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1052074 · Cited by 140
Zhang, L., Li, R., Chen, H., Wei, J., Qian, H., Su, S., Shao, J., Wang, L., Qian, X., & Liu, B. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s126016 · Cited by 137
Self-citationFu, Q., Lv, P., Chen, Z.-K., Ni, D., Zhang, L., Yue, H., Yue, Z., Wei, W., & Ma, G. (2015) · Nanoscale · doi:10.1039/c4nr07027e · Cited by 130
Wang, F., Fang, R. H., Luk, B. T., Hu, C. J., Thamphiwatana, S., Dehaini, D., Angsantikul, P., Kroll, A. V., Pang, Z., Gao, W., et al. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201505231 · Cited by 126
In Situ Capture of Bacterial Toxins for Antivirulence Vaccination
Wei, X., Gao, J., Wang, F., Man, Y. M., Angsantikul, P., Kroll, A. V., Zhou, J., Gao, W., Lu, W., Fang, R. H., et al. (2017) · Advanced Materials · doi:10.1002/adma.201701644 · Cited by 118
Sintnicolaas, K., Kooij, M. V. M., van Prooijen, H. C., van Dijk, B., van Putten, W., Claas, F. H. J., Novotny, V., & Brand, A. (1995) · Blood · doi:10.1182/blood.v85.3.824.bloodjournal853824 · Cited by 115
Rao, L., He, Z., Meng, Q., Zhou, Z., Bu, L., Guo, S., Liu, W., & Zhao, X. (2016) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35927 · Cited by 114
Pang, L., Zhang, C., Qin, J., Han, L., Li, R., Hong, C., He, H., & Wang, J. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1230903 · Cited by 100
Self-citationInternational seminar on the red blood cells as vehicles for drugs
Godfrin, Y., Horand, F., Franco, R. S., Dufour, E., Kosenko, E. A., Bax, B. E., Banz, A., Skorokhod, O. A., Lanao, J. M., Vitvitsky, V., et al. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.631909 · Cited by 87
How Leucocyte Cell Membrane Modified Janus Microcapsules are Phagocytosed by Cancer Cells
He, W., Frueh, J., Wu, Z., & He, Q. Z. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b10885 · Cited by 57
Molecular mechanisms of cell recruitment to inflammatory sites: general and tissue-specific pathways
Garrood, T., Lee, L., & Pitzalis, C. (2005) · Rheumatology · doi:10.1093/rheumatology/kei207 · Cited by 55
Differential MHC class I expression in distinct leukocyte subsets
Greene, J., Wiseman, R. W., Lank, S. M., Bimber, B. N., Karl, J. A., Burwitz, B. J., Lhost, J. J., Hawkins, O. E., Kunstman, K., Broman, K. W., et al. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-39 · Cited by 40
Cited by
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073
Xia, Q., Zhang, Y., Li, Z., Hou, X., & Feng, N. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.01.011 · Cited by 665
Immune Cell Membrane‐Coated Biomimetic Nanoparticles for Targeted Cancer Therapy
Oroojalian, F., Beygi, M., Baradaran, B., Mokhtarzadeh, A., & Shahbazi, M. (2021) · Small · doi:10.1002/smll.202006484 · Cited by 528
Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers
Zhao, Z., Ukidve, A., Krishnan, V., & Mitragotri, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.002 · Cited by 444
Metadata
- Authors
- Li, R., He, Y., Zhang, S., Qin, J., & Wang, J.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 8
- Issue
- 1
- Pages
- 14-22
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W2780622257
- Cited by
- 430
- References
- 81
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.